Medicare Enrolled

Dr. David Siegel, MD

Hematology · Hackensack, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
92 2ND ST, Hackensack, NJ 07601
5519968704
Registered in NPPES since 2006
NPI: 1457310815 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Siegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siegel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Siegel

Dr. David Siegel is a hematology specialist in Hackensack, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Siegel performed 5,604 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Siegel received a total of $271,012 from 29 pharmaceutical and/or device companies across 245 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Siegel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 41% volume in NJ $271,012 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,604
Medicare services
Top 41% in NJ for hematology
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
3,120 $6 $39
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
1,401 $149 $301
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
495 $102 $238
Pegfilgrastim-cbqv injection
An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg.
312 $107 $868
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
110 $12 $74
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
68 $28 $57
New patient office visit, complex (60-74 min) 35 $192 $457
Bone marrow smear interpretation
A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities.
25 $58 $323
Bone marrow aspiration
A procedure to remove a small sample of liquid bone marrow for diagnostic testing.
19 $71 $573
Biopsy of bone marrow 19 $146 $619
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$271,012
Total received (2018-2024)
Avg $38,716/year across 7 years
Top 18% in NJ for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
245
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,877
2023
$22,750
2022
$19,530
2021
$16,196
2020
$32,297
2019
$63,198
2018
$108,165

Payments by company (2024)

F. Hoffmann-La Roche AG
$3,095
Janssen Biotech, Inc.
$2,510
E.R. Squibb & Sons, L.L.C.
$2,453
Karyopharm Therapeutics Inc.
$249
Regeneron Pharmaceuticals, Inc.
$178
PFIZER INC.
$166
Adaptive Biotechnologies Corporation
$68
AstraZeneca Pharmaceuticals LP
$60
Celgene Corporation
$57
GENZYME CORPORATION
$23
ABBVIE INC.
$17
Top 3 companies account for 90.8% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$72,749
Amgen Inc.
$65,480
Takeda Pharmaceuticals U.S.A., Inc.
$50,563
E.R. Squibb & Sons, L.L.C.
$23,352
GlaxoSmithKline, LLC.
$13,050
Janssen Global Services, LLC
$8,470
Janssen Biotech, Inc.
$7,480
Celularity, Inc.
$5,085
Pharmacyclics LLC, An AbbVie Company
$3,590
PFIZER INC.
$3,581
F. Hoffmann-La Roche AG
$3,095
GENZYME CORPORATION
$2,909
Karyopharm Therapeutics Inc.
$2,482
Merck Sharp & Dohme LLC
$2,135
Genentech, Inc.
$2,045
Merck Sharp & Dohme Corporation
$2,000
Celularity Inc.
$1,000
Janssen Research & Development, LLC
$955
MENARINI SILICON BIOSYSTEMS, INC.
$500
Regeneron Pharmaceuticals, Inc.
$178
Adaptive Biotechnologies Corporation
$120
AstraZeneca Pharmaceuticals LP
$60
SANOFI-AVENTIS U.S. LLC
$26
Pharmacyclics LLC, an AbbVie Company
$23
Secura Bio, Inc.
$23
ABBVIE INC.
$17
The Binding Site Inc.
$15
Regeneron Healthcare Solutions, Inc.
$15
Collegium Pharmaceutical, Inc.
$15
Top 3 companies account for 69.7% of all-time payments
Associated products mentioned in payments ›
BB-2121 · BLENREP · BOSULIF · Blincyto · CARVYKTI · CHANTIX · Cellsearch · DARZALEX · ELITEK · ELREXFIO · EMPLICITI · EPKINLY · FARYDAK · FREELITE · IMBRUVICA · Imbruvica · KEYTRUDA · Kyprolis · LIBTAYO · NINLARO · Nplate · Pomalyst · Revlimid · SARCLISA · VENCLEXTA · XPOVIO · Xtampza ER · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Hackensack?
Compare hematologists in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
132
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Siegel is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Siegel experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Siegel performed 3,120 epoetin alfa injection (procrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Siegel receive payments from pharmaceutical companies?
Yes. Dr. Siegel received a total of $271,012 from 29 companies across 245 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siegel's costs compare to other hematologists in Hackensack?
Dr. Siegel's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →